Cargando…

Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis

This study aimed to evaluate the risk factors for end-stage renal disease (ESRD) in microscopic polyangiitis (MPA). In total, 74 patients with MPA were enrolled, and we compared the baseline clinical characteristics and disease activity between MPA patients who have progressed to ESRD and those with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuda, Shogo, Oe, Katsumasa, Kotani, Takuya, Okazaki, Ayana, Kiboshi, Takao, Suzuka, Takayasu, Wada, Yumiko, Shiba, Hideyuki, Hata, Kenichiro, Shoda, Takeshi, Takeuchi, Tohru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572948/ https://www.ncbi.nlm.nih.gov/pubmed/37833884 http://dx.doi.org/10.3390/ijms241914436

Ejemplares similares

Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease
por: Matsuda, Shogo, et al.
Publicado: (2021)

Risk prediction model for mortality in microscopic polyangiitis: multicentre REVEAL cohort study
por: Kotani, Takuya, et al.
Publicado: (2023)

Association between Serum Biomarkers and Peripheral Neuropathy in Microscopic Polyangiitis
por: Masuda, Yuichi, et al.
Publicado: (2022)

Low-Molecular-Weight Heparin Enhanced Therapeutic Effects of Human Adipose-Derived Stem Cell Administration in a Mouse Model of Lupus Nephritis
por: Matsuda, Shogo, et al.
Publicado: (2022)

Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
por: Suzuka, Takayasu, et al.
Publicado: (2022)

The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease
por: Wakura, Reiko, et al.
Publicado: (2020)

Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan
por: Sugiyama, Koichi, et al.
Publicado: (2012)

Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis
por: Harigai, Masayoshi, et al.
Publicado: (2019)

The influence of the Great East Japan earthquake on microscopic polyangiitis: A retrospective observational study
por: Takeuchi, Yoichi, et al.
Publicado: (2017)

Microscopic Polyangiitis in Systemic Sclerosis
por: Hashimoto, Hiroshi
Publicado: (2010)

Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab
por: Geetha, Duvuru, et al.
Publicado: (2014)

Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
por: Shah, Shivani, et al.
Publicado: (2015)

Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis
por: Merkel, Peter A., et al.
Publicado: (2021)

Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis
por: Samson, Maxime, et al.
Publicado: (2023)

Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis
por: Villeneuve, Thomas, et al.
Publicado: (2023)

Microscopic polyangiitis associated with thymic tumor: a case report and review of the literature
por: Miyamoto, Yasunori, et al.
Publicado: (2019)

Deep vein thrombosis: An unusual way of revealing microscopic polyangiitis. Deep vein thrombosis in microscopic polyangiitis
por: Jerbi, Mouna, et al.
Publicado: (2020)

Microscopic polyangiitis associated with subarachnoid hemorrhage
por: Ihara, Katsuhito, et al.
Publicado: (2019)

Microscopic Polyangiitis Initially Presumed to Be Endocarditis
por: Kaneko, Takahiro, et al.
Publicado: (2020)

Pre-Treatment Ferritin Level and Alveolar-Arterial Oxygen Gradient Can Predict Mortality Rate Due to Acute/Subacute Interstitial Pneumonia in Dermatomyositis Treated by Cyclosporine A/Glucocorticosteroid Combination Therapy: A Case Control Study
por: Isoda, Kentaro, et al.
Publicado: (2014)

Dermatomyositis as a complication of interferon-α therapy: a case report and review of the literature
por: Shiba, Hideyuki, et al.
Publicado: (2014)

Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis
por: Iudici, Michele, et al.
Publicado: (2016)

The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis
por: Pyo, Jung Yoon, et al.
Publicado: (2021)

Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis
por: Ahn, Sung Soo, et al.
Publicado: (2021)

Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report
por: Matsuda, Shogo, et al.
Publicado: (2022)

Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply
por: Matsuda, Shogo, et al.
Publicado: (2022)

Clinical Features and Outcomes of Microscopic Polyangiitis in Korea
por: Oh, Ji Seon, et al.
Publicado: (2009)

Paraneoplastic microscopic polyangiitis presenting after thymectomy
por: Tracey, Elisabeth H., et al.
Publicado: (2016)

The Clinical and Pathological Features of Children With Microscopic Polyangiitis
por: Li, Qian, et al.
Publicado: (2021)

Tozinameran: Relapse of microscopic polyangiitis: case report
Publicado: (2021)

Serum 20S proteasome levels are associated with disease activity in MPO-ANCA-associated microscopic polyangiitis
por: Maruyama, Hiroshi, et al.
Publicado: (2020)

Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis
por: Deshayes, Samuel, et al.
Publicado: (2018)

Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study
por: Shiba, Hideyuki, et al.
Publicado: (2023)

Clinical characteristics of patients with granulomatosis with polyangiitis and microscopic polyangiitis in ENT practice: a comparative analysis
por: WOJCIECHOWSKA, J., et al.
Publicado: (2018)

Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator
por: Kwon, Hyeok Chan, et al.
Publicado: (2020)

Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report
por: Ide, Hiroyuki, et al.
Publicado: (2022)

Association between sinusitis and relapse and changes in the myeloperoxidase–antineutrophil cytoplasmic antibody in microscopic polyangiitis
por: Tanaka, Hiroya, et al.
Publicado: (2020)

Rituximab is a therapeutical option for juvenile microscopic polyangiitis
por: Brunner, J, et al.
Publicado: (2008)

Pleural vasculitides of microscopic polyangiitis with asbestos‐related plaques
por: Hara, Ayako, et al.
Publicado: (2015)

Microscopic polyangiitis preceded by combined pulmonary fibrosis and emphysema
por: Gocho, Kyoko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dkkjmo4r1o3kppl577678f2gjd